IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	812.38B
Revenue (ttm)	80.36B
Net Income (ttm)	18.29B
Shares Out	n/a
EPS (ttm)	221.05
PE Ratio	44.41
Forward PE	41.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	14
Open	10,041
Previous Close	10,041
Day's Range	10,041 - 10,041
52-Week Range	7,650 - 10,041
Beta	n/a
RSI	86.51
Earnings Date	May 1, 2025

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD